PBA
Paradigm Biocapital Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,719,831
| Closed | -$11.5M | – | 25 |
|
|
2022
Q3 | $11.5M | Buy |
1,719,831
+311,781
| +22% | +$2.09M | 1.54% | 19 |
|
|
2022
Q2 | $8.96M | Buy |
1,408,050
+250,804
| +22% | +$1.6M | 1.79% | 15 |
|
|
2022
Q1 | $5.37M | Buy |
1,157,246
+317,989
| +38% | +$1.48M | 1.42% | 22 |
|
|
2021
Q4 | $4.2M | Buy |
+839,257
| New | +$4.2M | 1.2% | 23 |
|